Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-29 @ 1:55 PM
Study NCT ID:
NCT00867308
Status:
TERMINATED
Last Update Posted:
2018-10-17
First Post:
2009-03-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-19
First Submit QC Date:
None
Study First Post Date:
2009-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-21
Results First Submit QC Date:
None
Results First Post Date:
2018-10-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-21
Last Update Post Date:
2018-10-17
Last Update Post Date Type:
ACTUAL